SYHA1813, a vascular endothelial growth factor receptor (VEGFR) 1-3/colony-stimulating factor 1 receptor (CSF1R) inhibitor, in patients with recurrent glioblastoma

被引:0
|
作者
Li, W. [1 ]
Kang, Z. [1 ]
Chen, F. [1 ]
Li, S. [1 ]
Zhang, B. [1 ]
Huang, M. [1 ]
Yang, X. [2 ]
She, F. [2 ]
Xiang, S. [2 ]
Liu, G. [2 ]
Liu, M. [2 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Neuro Oncol Dept, Beijing, Peoples R China
[2] CSPC Pharmaceut Grp Ltd, Dept Clin Dev, Shijiazhuang, Hebei, Peoples R China
关键词
D O I
10.1016/j.annonc.2024.08.516
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
446MO
引用
收藏
页码:S408 / S408
页数:1
相关论文
共 50 条
  • [1] A phase I dose-expansion cohort of SYHA1813, a vascular endothelial growth factor receptor (VEGFR) 1-3 /colony-stimulating factor 1 receptor (CSF1R) inhibitor, in patients (pts) with recurrent meningioma
    Li, W.
    Kang, Z.
    Wu, Z.
    Li, S.
    Huang, M.
    Pu, W.
    Yang, X.
    Lin, J.
    Liu, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S394 - S395
  • [2] Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
    Cannarile, Michael A.
    Weisser, Martin
    Jacob, Wolfgang
    Jegg, Anna-Maria
    Ries, Carola H.
    Ruettinger, Dominik
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [3] Functional evolution of the colony-stimulating factor 1 receptor (CSF1R) and its ligands in birds
    Hume, David A.
    Gutowska-Ding, Maria W.
    Garcia-Morales, Carla
    Kebede, Adebabay
    Bamidele, Oladeji
    Trujillo, Adriana Vallejo
    Gheyas, Almas A.
    Smith, Jacqueline
    JOURNAL OF LEUKOCYTE BIOLOGY, 2020, 107 (02) : 237 - 250
  • [4] The transcriptional regulation of the Colony-Stimulating Factor 1 Receptor (csf1r) gene during hematopoiesis
    Bonifer, Constanze
    Hume, David A.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 549 - 560
  • [5] PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R)
    Horti, Andrew G.
    Naik, Ravi
    Foss, Catherine A.
    Minn, Il
    Misheneva, Varia
    Du, Yong
    Wang, Yuchuan
    Mathews, William B.
    Wu, Yunkou
    Hall, Andrew
    LaCourse, Catherine
    Ahn, Hye-Hyun
    Nam, Hwanhee
    Lesniak, Wojciech G.
    Valentine, Heather
    Pletnikova, Olga
    Troncoso, Juan C.
    Smith, Matthew D.
    Calabresi, Peter A.
    Savonenko, Alena V.
    Dannals, Robert F.
    Pletnikov, Mikhail V.
    Pomper, Martin G.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (05) : 1686 - 1691
  • [6] Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival
    Luo, Jian
    Elwood, Fiona
    Britschgi, Markus
    Villeda, Saul
    Zhang, Hui
    Ding, Zhaoqing
    Zhu, Liyin
    Alabsi, Haitham
    Getachew, Ruth
    Narasimhan, Ramya
    Wabl, Rafael
    Fainberg, Nina
    James, Michelle L.
    Wong, Gordon
    Relton, Jane
    Gambhir, Sanjiv S.
    Pollard, Jeffrey W.
    Wyss-Coray, Tony
    JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 210 (01): : 157 - 172
  • [7] Colony Stimulating Factor Receptor 1 (CSF1R) Inhibition Impairs Liver Regeneration
    Santamaria-Barria, Juan A.
    Greer, Jonathan B.
    Zeng, Shan
    Seifert, Adrian M.
    Cohen, Noah A.
    Beckman, Michael J.
    Rossi, Ferdinand
    Crawley, Megan H.
    Green, Benjamin L.
    DeMatteo, Ronald P.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (03) : S24 - S24
  • [8] Colony-Stimulating Factor 1 Receptor (CSF1R) Regulates Microglia Density and Distribution, but Not Microglia Differentiation In Vivo
    Oosterhof, Nynke
    Kuil, Laura E.
    van der Linde, Herma C.
    Burm, Saskia M.
    Berdowski, Woutje
    van Ijcken, Wilfred F. J.
    van Swieten, John C.
    Hol, Elly M.
    Verheijen, Mark H. G.
    van Ham, Tjakko J.
    CELL REPORTS, 2018, 24 (05): : 1203 - +
  • [9] A phase I dose-escalation study of SYHA1813, a VEGFR and CSF1R inhibitor, in patients with recurrent High-Grade Gliomas or Advanced Solid Tumors
    Kang, Zhuang
    Li, Shenglan
    Lin, Yi
    Li, Yongsheng
    Mao, Ying
    Zhang, Jing
    Lei, Ting
    Wang, Haidan
    Su, Yangzhi
    Yang, Yang
    Qiu, Jingbo
    Li, Wenbin
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (02) : 296 - 305
  • [10] A phase 1 study of ARRY-382, an oral inhibitor of colony-stimulating factor-1 receptor (CSF1R), in patients with advanced or metastatic cancers
    Bendell, Johanna C.
    Tolcher, Anthony W.
    Jones, Suzanne F.
    Beeram, Muralidhar
    Infante, Jeffrey R.
    Larsen, Paul
    Rasor, Kevin
    Garrus, Jennifer E.
    Li, Jinfang
    Cable, P. Louann
    Eberhardt, Christine
    Schreiber, Jennifer
    Rush, Selena
    Wood, Kenneth W.
    Barret, Emma
    Patnaik, Amita
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)